Premas Life Sciences Private Limited

Premas Life Sciences Private Limited - healthcare in New, Delhi, India. FY 2026 financials & compliance.
CIN U51909DL2011PTC217592 Incorporated 15 April 2011 ROC Delhi HQ New, Delhi, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹309.66 Cr
▼ 2% YoY
Net profit · FY 2025
₹39.88 Cr
Net margin 12.9%
EBITDA · FY 2025
₹56.36 Cr
EBITDA margin 18.2%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹28.73 Cr
Issued & subscribed
Open charges
₹132 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
88
Provident fund records

About Premas Life Sciences Private Limited

Data last updated:

Premas Life Sciences Private Limited is a private limited company based in New, Delhi, India, recognised as a startup by DPIIT. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 15 April 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2011PTC217592. Its GSTIN is 07AAGCP0079F1ZI (Delhi). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹28.73 Cr. It is led by directors including Praveen Kumar Gupta (Managing Director) and Debjit Patra.

Its last annual general meeting (AGM) was held on 28 August 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Second Floor E – 49/5 Okhla Industrial Estate Phase – II, New, Delhi, India – 110020.

As per the financials filed for FY 2025, the company reported a revenue of ₹309.66 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹39.88 Cr (net margin 12.9%) and EBITDA of ₹56.36 Cr (EBITDA margin 18.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 29% over five years.

The company has about 88 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Premas Life Sciences. As per MCA filings, the company has open charges of ₹132 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website premaslifesciences.com.

Company Details of Premas Life Sciences Private Limited
CIN U51909DL2011PTC217592
Registration Number 217592
Incorporation Date 15 April 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 August 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Second Floor E – 49/5 Okhla Industrial Estate Phase – II, New, Delhi, India – 110020
  • Industry
    Healthcare, Medical Equipment Retail & Distribution
Comprehensive company report
Premas Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Premas Life Sciences Private Limited report

Financials, compliance, directors, charges, ownership and filings for Premas Life Sciences Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with Premas Life Sciences Private Limited

Premas Life Sciences operates one associated brand: Premas Life Sciences. Each brand links to its own profile.

BrandDescriptionWebsite
Distributes cutting-edge genomics tools for research, clinical diagnostics, and biotechnology applications.premaslifesciences.com

Competitors & Alternatives of Premas Life Sciences Private Limited

Brands and companies operating in the same space as Premas Life Sciences Private Limited include Nanopore, PacBio, QuantuMDx and 7 more.

CompetitorDescriptionLocationFounded
Nanopore Nanopore Nanopore-based electronic systems for single-molecule analysis are developed.Oxford, United Kingdom2005
PacBio PacBio Instrument systems and software for single-molecule real-time sequencing are developed.Menlo Park, United States2004
QuantuMDx QuantuMDx Handheld diagnostic and sequencing devices are developed for personalized healthcare.Newcastle Upon Tyne, United Kingdom2008
Complete Genomics Complete Genomics DNA sequencing platform for human genome analysis is developed.San Jose, United States2006
Omniome Omniome Genome sequencing platform is provided for clinical diagnostics.San Diego, United States2013
Stratos Genomics Stratos Genomics Nanopore-based single molecule sequencers are developed using SBX technology.Seattle, United States2007
GenapSys GenapSys Provider of DNA sequencing technologies for applied genomic testing and medical sequencingRedwood City, United States2010
Bionano Bionano Provider of genome analysis solutions to researchers and cliniciansSan Diego, United States2002
RainDance RainDance Developer of nucleic acid detection and quantification systemsBillerica, United States2004
Purigen Biosystems Purigen Biosystems Isotachophoresis technology is provided for nucleic acid sample preparation.Pleasanton, United States2012

Business Activity of Premas Life Sciences Private Limited

The main business activities of Premas Life Sciences are trade and professional, scientific and technical. In detail, this covers wholesale trading and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Premas Life Sciences Private Limited

Premas Life Sciences Private Limited is audited by R R Bajaj & Associates for the financial year 2023.

NameStatusAppointment DateCessation Date
R R Bajaj & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Premas Life Sciences Private Limited

Premas Life Sciences Private Limited currently reports 3 directors and 1 key managerial person. 3 former directors have served the organization.

Financials of Premas Life Sciences Private Limited FY 2024 filings available

Premas Life Sciences Private Limited reported revenue of ₹309.66 Cr (down 2% YoY) for FY 2025.

Revenue · FY 2025
₹309.66 Cr ▼ 2%
Net profit · FY 2025
₹39.88 Cr margin 12.9%
EBITDA · FY 2025
₹56.36 Cr margin 18.2%

Compounded Annual Growth Rate (CAGR) of Premas Life Sciences Private Limited

Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▼ 2%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▼ 15%
5 years · compounded
▲ 25%

Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 29%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Premas Life Sciences Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹56.36 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹39.88 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Premas Life Sciences Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin18.2%••••••••••••••••
Net Profit Margin12.9%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Premas Life Sciences are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Premas Life Sciences Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Premas Life Sciences Private Limited

Open charges
₹132 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹80.00 Cr
Others₹27.00 Cr
Citi Bank N.A.₹25.00 Cr
Latest charge details
DateLenderAmountStatus
22 Dec 2021Others₹27 CrOpen
29 Nov 2021Hdfc Bank Limited₹80 CrOpen
14 Mar 2019Citi Bank N.A.₹25 CrOpen

Total charge records: 3 View all charges

Employees and EPFO Compliance at Premas Life Sciences Private Limited

Premas Life Sciences Private Limited has a workforce of 88 employees as of Apr 04, 2024.

Employee count
88
Active EPFO establishments
1
Employee growth
7.32%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Premas Life Sciences Private Limited

Premas Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AAGCP0079F1ZIDelhiActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Premas Life Sciences Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Premas Life Sciences Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Premas Life Sciences Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Premas Life Sciences Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Premas Life Sciences Private Limited

Charges
26 Aug 2025
A charge with Hdfc Bank Limited of Rs. 80.00 Cr registered on 29 Nov 2021 with Charge ID 100504820 was modified on 26 Aug 2025.
Activity
28 Aug 2024
Premas Life Sciences Private Limited last Annual general meeting of members was held on 28 Aug 2024 as per latest MCA records.
Charges
01 Jul 2024
A charge with Others of Rs. 27.00 Cr registered on 22 Dec 2021 with Charge ID 100535456 was modified on 01 Jul 2024.
Activity
31 Mar 2024
Premas Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
27 Jul 2023
A charge with Citi Bank N.A. of Rs. 25.00 Cr registered on 14 Mar 2019 with Charge ID 100271765 was modified on 27 Jul 2023.
Directors
16 Feb 2023
Ritika Mundra was appointed as a Company Secretary on 16 Feb 2023 & has been associated with this company since 3 years 7 months.

Recent News on Premas Life Sciences Private Limited

Frequently Asked Questions about Premas Life Sciences Private Limited

Premas Life Sciences is an active private limited company based in New, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 15 April 2011 (15+ years old) and is registered under CIN U51909DL2011PTC217592.

Premas Life Sciences reported revenue of ₹309.66 Cr for FY 2025 (down 2% YoY).

Premas Life Sciences has 4 current directors and KMP:

Premas Life Sciences reported a net profit of ₹39.88 Cr (net margin 12.9%) and EBITDA of ₹56.36 Cr (EBITDA margin 18.2%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Premas Life Sciences is -2% over three years and 29% over five years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Premas Life Sciences is 07AAGCP0079F1ZI, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Premas Life Sciences is U51909DL2011PTC217592. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Premas Life Sciences was incorporated on 15 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.

Yes, Premas Life Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available